Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chula Vista, California 91911


Purpose:

This trial is conducted in the United States of America (USA). The aim of the trial is to compare the exposure of two formulations of insulin degludec/insulin aspart (NN5401) in healthy subjects.


Criteria:

Inclusion Criteria: - Considered generally healthy upon completion of medical history, physical examination, vital signs and electrocardiogram (ECG), as judged by the physician - Body mass index between 18.0 and 27.0 kg/m^2 (both inclusive) Exclusion Criteria: - Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to trial start - Smoker (defined as a subject who is smoking more than 5 cigarettes or the equivalent per day) - Not able or willing to refrain from smoking and use of nicotine gum or transdermal nicotine patches during the inpatient period


NCT ID:

NCT01125553


Primary Contact:

Study Director
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S


Backup Contact:

N/A


Location Contact:

Chula Vista, California 91911
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.